141352-95-6

Basic information

• Product Name: Diethyl methyl-p-nitrobenzyl-malonate
• Synonyms: Diethyl methyl-p-nitrobenzyl-malonate
• CAS NO: 141352-95-6
• Molecular Weight: 309.319
• Mol File: 141352-95-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Diethyl methyl-p-nitrobenzyl-malonate(CAS DataBase Reference)
• NIST Chemistry Reference: Diethyl methyl-p-nitrobenzyl-malonate(141352-95-6)
• EPA Substance Registry System: Diethyl methyl-p-nitrobenzyl-malonate(141352-95-6)

Safety Data

• Hazardous Substances Data: 141352-95-6(Hazardous Substances Data)

Upstream product

• 609-08-5 Diethyl methylmalonate 
• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 100-14-1 4-nitrobenzyl chloride 

Downstream Products

• 144872-10-6 diethyl 2-(4-aminobenzyl)-2-methylmalonate 
• 1333468-72-6 diethyl 2-(4-(piperazin-1-yl)benzyl)-2-methylmalonate 
• 1333468-73-7 diethyl 2-(4-(4-methylpiperazin-1-yl)benzyl)-2-methylmalonate 
• 1333468-74-8 2-(4-(4-methylpiperazin-1-yl)benzyl)propanoic acid 
• 1333468-75-9 2-(4-(4-methylpiperazin-1-yl)benzyl)propanamide 
• 141353-00-6 1-<4-<2-(Carboethoxy)-propyl>-benzyl>-1H-1,2,3-triazole 
• 141352-99-0 1-<4-<2-(Carboxy)-propyl>-benzyl>-1H-1,2,3-triazole 
• 141352-98-9 2--propionic acid 
• 60423-91-8 rac-3-(4-cyanophenyl)-2-methylpropanoic acid 
• 141352-97-8 2--propionic acid 
• 141352-96-7 2--propionic acid 
• 103096-03-3 (±)-3-(4-aminophenyl)-2-methylpropanoic acid 
• 52787-39-0 2-(p-Formylbenzyl)-propionic acid 
• 66735-03-3 2-methyl-3-(4-nitrophenyl)propanoic acid 

Relevant articles and documents

Inhibitors of protein kinases

Compounds of general Formula (I): wherein R1, R2, R3, Ra, A, B and x are as defined herein are inhibitors of protein kinases in particular members of the cyclin-dependent kinase family and/or the glycogen synthase kinase 3 family and are useful in preventing and/or treating any type of pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases and neurodegenerative diseases.

Phenylmercaptotetrazolo- and nitroindazolo masked development/image modifiers

Novel nitrobenzyl compounds are incorporated into a photographic emulsion or developer for controlled release of development/image modifier compounds. This occurs imagewise only after developer oxidation products have been formed in the course of the development process. For example, nitrobenzyl-masked phenylmercaptotetrazole (PMT), incorporated into a silver halide emulsion, reacts with developer oxidation products via an electron transfer mechanism to release the potent development restrainer PMT.